NEWS
Our Latest News
ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden
ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden
As part of the transaction, Nihon Kohden, one of the largest developers and distributors of medical electronic equipment in the world, is entering a joint-venture with ARCHIMED to pursue Ad-Tech’s growth in North America, Europe, and Asia.
ARCHIMED buys a majority stake in SUANFARMA a leading manufacturer and distributor of active pharmaceutical and nutraceutical ingredients
November
18,
2021
ARCHIMED buys Cube, an innovative provider of membrane protein services for the biopharma research market
November
3,
2021
ARCHIMED refinances Ad-Tech less than a year after purchase, returning more than a third of investment to shareholders
October
20,
2021
ARCHIMED’s NAMSA returns more than a third of investment
October
7,
2021
368